Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management

SYC Tong, JS Davis, E Eichenberger… - Clinical microbiology …, 2015 - Am Soc Microbiol
Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as …

[HTML][HTML] Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa

NA Feasey, G Dougan, RA Kingsley, RS Heyderman… - The Lancet, 2012 - thelancet.com
Invasive strains of non-typhoidal salmonellae have emerged as a prominent cause of
bloodstream infection in African adults and children, with an associated case fatality of 20 …

Antimicrobial peptides and small molecules targeting the cell membrane of Staphylococcus aureus

N Ganesan, B Mishra, LO Felix… - … and Molecular Biology …, 2023 - Am Soc Microbiol
Clinical management of Staphylococcus aureus infections presents a challenge due to the
high incidence, considerable virulence, and emergence of drug resistance mechanisms …

[HTML][HTML] Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia

S Weis, M Kesselmeier, JS Davis, AM Morris… - Clinical Microbiology …, 2019 - Elsevier
Background For patients with bacteraemia caused by methicillin-sensitive Staphylococcus
aureus anti-staphylococcal penicillins (ASPs) or cefazolin are agents of choice. While ASPs …

[HTML][HTML] Population-based study of bloodstream infection incidence and mortality rates, Finland, 2004–2018

KSK Kontula, K Skogberg, J Ollgren… - Emerging Infectious …, 2021 - ncbi.nlm.nih.gov
We evaluated the incidence, outcomes, and causative agents of bloodstream infections
(BSI) in Finland during 2004–2018 by using data from the national registries. We identified a …

Epidemiology and mortality of Staphylococcus aureus bacteremia in Australian and New Zealand children

BJ McMullan, A Bowen, CC Blyth, S Van Hal… - JAMA …, 2016 - jamanetwork.com
Importance Staphylococcus aureusbacteremia (SAB) in children causes significant morbidity
and mortality, but the epidemiology in children is not well characterized. Objective To …

Association of evidence-based care processes with mortality in Staphylococcus aureus bacteremia at Veterans Health Administration hospitals, 2003-2014

M Goto, ML Schweizer… - JAMA internal …, 2017 - jamanetwork.com
Importance Staphylococcus aureusbacteremia is common and frequently associated with
poor outcomes. Evidence indicates that specific care processes are associated with …

Early Oral Switch to Linezolid for Low-risk Patients With Staphylococcus aureus Bloodstream Infections: A Propensity-matched Cohort Study

R Willekens, M Puig-Asensio… - Clinical Infectious …, 2019 - academic.oup.com
Treatment of Staphylococcus aureus bloodstream infections in selected low-risk patients
with an early oral switch to linezolid between days 3 and 9 of treatment until completion …

[HTML][HTML] Age-dependent increase in incidence of Staphylococcus aureus bacteremia, Denmark, 2008–2015

L Thorlacius-Ussing, H Sandholdt… - Emerging Infectious …, 2019 - ncbi.nlm.nih.gov
Staphylococcus aureus bacteremia (SAB) is a major cause of illness and death worldwide.
We analyzed temporal trends of SAB incidence and death in Denmark during 2008–2015 …

Comprehensive genomic investigation of adaptive mutations driving the low-level oxacillin resistance phenotype in Staphylococcus aureus

SG Giulieri, R Guérillot, JC Kwong, IR Monk, AS Hayes… - MBio, 2020 - Am Soc Microbiol
Antistaphylococcal penicillins such as oxacillin are the key antibiotics in the treatment of
invasive methicillin-susceptible Staphylococcus aureus (MSSA) infections; however, mec …